Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Pescovitz, Mark D., Greenbaum, Carla J., Krause-Steinrauf, Heidi, Becker, Dorothy J., Gitelman, Stephen E., Goland, Robin, Gottlieb, Peter A., Marks, Jennifer B., McGee, Paula F., Moran, Antoinette M., Raskin, Philip, Rodriguez, Henry, Schatz, Desmond A., Wherrett, Diane, Wilson, Darrell M., Lachin, John M., Skyler, Jay S.·2009·New England Journal of Medicine
DOI 10.1056/nejmoa0904452

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Targeting innate immunity in type 1 diabetes: strike one
    Ezio E. Bonifacio · 2013 · The Lancet
  2. Diabetes Mellitus tipo 1 e hepatite autoimune como forma de apresentação precoce da síndrome poliglandular autoimune tipo II
    Diana Moreira, Isabel Pinto Pais, Sandra Rebimbas, Luciana Barbosa, Lúcia Rodrigues, Cristina S. Costa, Rosa Arménia Campos · 2012 · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
  3. B-Lymphocyte Therapy for Type 2 Diabetes: The ‘B‘ Side of Diabetic Medication?
    Shane T. Grey · 2013 · Immunotherapy
  4. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
    J.A. Stockman · 2011 · Yearbook of Pediatrics
  5. Evaluation of Preventive Studies in Type 1 Diabetes Mellitus
    Müyesser Saykı Arslan, Oya Topaloğlu, Mustafa Şahi̇n, Tuncay Delibaşı · 2013 · Endocrinology research and practice.
  6. Changing perspectives on the progression of type 1 diabetes
    Noel G. Morgan, Sarah J. Richardson · 2016 · Practical Diabetes
  7. Diabetes and Health Care: An Overview
    M Abhilash, Robin Augustine · 2014 · Apple Academic Press eBooks
  8. Immunopathology of the Endocrine System
    Thomas J. Rosol, Brent E. Walling · 2017 · Molecular and integrative toxicology
  9. Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation
    George William Burke, Gaetano Ciancio, Mahmoud Morsi, Jose Figueiro, Linda Chen, Francesco Vendrame, Alberto Pugliese · 2018 · Current Transplantation Reports
  10. Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to Protection
    Darshan Badal, Mahinder Paul, Neenu Jacob, Naresh Kumar Sachdeva · 2020 · Springer eBooks
  11. Autoimmune (Type 1) Diabetes
    Ahmed J. Delli, Åke Lernmark · 2013 · Elsevier eBooks
  12. Inzulin A-lánca elleni autoreaktív T-sejtek izolálhatóak újonnan diagnosztizált 1-es típusú cukorbetegek véréből
    János Tibor Kis, Péter Engelmann, Tihamer Orban · 2021 · Diabetologia Hungarica
  13. Prediction of autoimmune diseases: From bench to bedside
    Álvaro J. Vivas, Gabriel Jaime Tobón · 2022 · Elsevier eBooks
  14. Diabetes and Health Care
    M Abhilash, Robin Augustine · 2014 · Apple Academic Press eBooks
  15. Rituximab
    Claire Wood, Gerry McKay, Miles Fisher · 2017 · Practical Diabetes
  16. Stress and human health in diabetes: A report from the 19th Chicago Biomedical Consortium symposium
    R. Mirmira, R. N. Kulkarni, Pingwen Xu, Tina Drossos, K. Varady, Kristen Knutson, S. Reutrakul, P. Martyn-Nemeth, R. Sargis, A. Wallia et al. · 2023 · Journal of Clinical and Translational Science
  17. The Present and Future of Type 1 Diabetes Prevention: Teplizumab and Immunomodulators
    Heeseok Sohn, Sujong Kim, Jeong-Hyun Yoon · 2024 · Korean Journal of Clinical Pharmacy
  18. Efficacy of immunosuppression in preserving beta cell function and reducing insulin requirements in Type 1 diabetes mellitus: a comprehensive review
    S Pillay, A Pillay, A Kalhan · 2025 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  19. Hyaluronan Accumulates in Inflamed Lymph Nodes and Promotes B‐Cell Activation
    Zhiwei Li, Nadine Nagy, Gernot Kaber, Payton L. Marshall, Naomi L. Haddock, Everett H. Meyer, Robert R. Vernon, Manish J. Butte, Ovijit Chaudhuri, Thomas N. Wight et al. · 2025 · Proteoglycan Research
  20. Tertiärprävention des Typ-1-Diabetes
    S. Link, Nanette Cathrin Schloot · 2011 · Der Diabetologe
  21. Inmunoterapia en diabetes mellitus tipo 1. ¿Quo vadis?
    Mercè Fernández-Balsells, Lidia Sojo-Vega, Wifredo Ricart · 2013 · Avances en Diabetología
  22. Immunotherapy for Type 1 diabetes: past and future
    Mona Landin‐Olsson, Charlotte Erlanson‐Albertsson · 2012 · Diabetes Management
  23. Prevention of Autoimmune Disease
    Leonard C. Harrison, John M. Wentworth · 2013 · Elsevier eBooks
  24. Pathogenesis of Type 1 Diabetes
    Alberto Pugliese · 2018 · Endocrinology
  25. Monoclonal Antibodies and Its Clinical Aspects
    Mohamadu Maharuf Mohamed Shafras, Mohamed Rafeek Rukshan Ahamed, Geetika Pant · 2017 · DOAJ (DOAJ: Directory of Open Access Journals)
  26. Future Strategies in Management of Diabetes Mellitus: A Brief Report
    Alok Pratap Singh, Anuj Kumar · 2019 · International Journal of Medical Reviews and Case Reports
  27. Disease-modifying Therapies for the Prevention of Type 1 Diabetes
    Carla J. Greenbaum · 2019 · US Endocrinology
  28. Emerging Biological and Molecular Therapies in Autoimmune Disease
    Lucienne Chatenoud · 2019 · Elsevier eBooks
  29. Recurrence of type 1 diabetes after beta-cell replacement
    Paolo Monti · 2019 · Elsevier eBooks
  30. An Update on the Immunotherapy Strategies for the Treatment of Type 1 Diabetes (TID)-How Far have we Reached in Reaching Insulin Independency in TID therapy-A Systematic Review
    Kulvinder Kochar Kaur · 2020 · Open Access Journal of Endocrinology
  31. Autoimmune Endocrine Disorders
    Jennifer M. Barker · 2013 · Humana Press eBooks
  32. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy
    Åke Lernmark, Helena Elding Larsson · 2011 · Journal of Internal Medicine
  33. Preservation of beta cell function
    Mark A. Sperling · 2009 · Pediatric Diabetes
  34. Immune and cell therapy in type 1 diabetes: too little too late?
    Pieter Gillard, Chantal Mathieu · 2011 · Expert Opinion on Biological Therapy
  35. Vitamin D3Supplementation to Preserve Pancreatic β-Cell Function in Newly Diagnosed Type 1 Diabetic Patients
    Sheela Natesh Magge · 2012 · Archives of Pediatrics and Adolescent Medicine
  36. The Role of B Cells in Transplantation and Immunopathic Diseases
    Antony Basten · 2010 · Immune Network
  37. In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?
    Johnny Ludvigsson · 2012 · Expert Review of Vaccines
  38. Diabetes vaccines: review of the clinical evidence
    Johnny Ludvigsson · 2011 · Clinical Investigation
  39. ACTA UNIVERSITATIS OULUENSIS D Medica 1372
    Anne Hekkala · 2016
  40. The Importance of CD19+ Cells from Pre-diabetic NOD Mice in Delaying Onset of Disease in an Adoptive Transfer Model of Type 1 Diabetes Mellitus
    Andrew D. Vonberg · 2017 · Deep Blue (University of Michigan)
  41. O receptor NLRP1 atua como um regulador do perfil de resposta Th17 em modelos experimentais e em humanos com diabetes tipo 1
    Frederico R. C. Costa · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  42. Ocrelizumab: A New Generation of anti‐ CD20 mAb for Treatment of Multiple Sclerosis
    Andrew C. Chan, Paul G. Brunetta, Peter Chin · 2019 · Wiley eBooks
  43. WITHDRAWN: Combined therapy of adenovirus vector mediated IGF-1 gene with anti-CD20 mAbs exerts potential beneficial role on type 1 diabetes in nonobese diabetic mice
    Xiaoxiao Zhu, Fei Bian, Yuchen Zhao, Yanyan Qin, Xiang Sun, Lanlan Zhou · 2021 · Life Sciences · Retracted
  44. Endocrine Autoimmunity
    Simon H. S. Pearce, Catherine J. Owen · 2022
  45. Diabetes Mellitus
    Geoffrey R. Ambler, Fergus J. Cameron, Kriti Joshi, Diane K. Wherrett · 2019 · Wiley eBooks
  46. Autoimmunity
    Kazuhiko Yamamoto, Mark Jay Shlomchik · 2010 · Current Opinion in Immunology
  47. Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients
    Catherine A. Nicholas, Fatima Tensun, Spencer A. Evans, Kevin P. Toole, HALI C. BRONCUCIA, Jay R. Hesselberth, Peter A. Gottlieb, Kristen L. Wells, Mia J. Smith · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  48. The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 Diabetes
    Graham L. Barlow, Christian M. Schürch, Salil S. Bhate, Darci J. Phillips, Arabella Young, Shen Dong, HA Martinez, Gernot Kaber, Nadine Nagy, S Ramachandran et al. · 2024 · eLife
  49. The minor spliceosome is a master immune regulator
    MB Johnson, James Russ‐Silsby, Paul A. Blair, Molly Govier, Georgia Bonfield, Clara Domingo‐Vila, Matthew Neil Wakeling, Richard A. Oram, Sarah Elizabeth Flanagan, Timothy I. M. Tree et al. · 2025 · medRxiv
  50. Interplay between inflammation, autoimmunity and regeneration in the NOD mouse model of type 1 diabetes and Sjogren’s Syndrome.
    Elisa Astorri · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  51. Molecular characterisation of Epstein-Barr virus-specific B cell response
    Archana Panikkar · 2015 · The University of Queensland
  52. Understanding Pancreatic Secretion in Type 1 Diabetes
    Mirella Hansen de Almeida, Alessandra Saldanha de Mattos Matheus, Giovanna A. Balarini Lim · 2011 · InTech eBooks
  53. A study of biomarker analysis in association with type 1 diabetes and their shared features in rheumatoid arthritis
    Chengjun Sun · 2014 · Figshare
  54. A 'cure' for diabetes and its complications
    Kim C. Donaghue, Tony Keech, Maria E. Craig, Philip J. O’Connell · 2012 · The Sydney eScholarship Repository (The University of Sydney)
  55. Glycemic treatment of diabetes mellitus
    Harpreet Kaur, Ruth S. Weinstock · 2014 · Wiley eBooks
  56. Host-microbe interactions in coxsackievirus infection : Focus on innate immunity
    Michael H. Hühn · 2010 · Figshare
  57. Immunotherapies for Type 1 Diabetes
    Werner Gürr · 2013 · InTech eBooks
  58. Identificação de cascatas gênicas com base na modulação transcricional de células sanguíneas mononucleares periféricas de pacientes com diabetes mellitus do tipo 1
    Thaís Arns · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  59. Modulation of TCR signals reprograms immune tolerance in transplantation and type-1 diabetes
    Mithun Khattar · 2012 · OhioLink ETD Center (Ohio Library and Information Network)
  60. Genetic and Immunological Mechanisms Regulating Neuroinflammation
    Alan Gillett · 2010 · Figshare
  61. Prevention Opportunities of Type 1 Diabetes in Children
    Alaeddin Saghir · 2015 · Endocrinology&Metabolism International Journal
  62. Keeping the patient perspective: Where are we in the world of type 1 diabetes?
    Jeremy Pettus, Matthias von Herrath · 2013 · Clinical Immunology
  63. P2 B cell depletion therapy exacerbates murine primary biliary cirrhosis
    Ana Lleò, Francesca Bernuzzi, Luca Moroni, Ilaria Bianchi, REBECCA C. DUNN, Marilyn R. Kehry, Thomas Alexander Packard, John C. Cambier, Mauro Podda, M. Eric Gershwin et al. · 2010 · Digestive and Liver Disease
  64. Selective depletion of B lymphocytes with rituximab preserves β-cell function
    Vicky Heath · 2010 · Nature Reviews Endocrinology
  65. Role of B cells in the development of multiple sclerosis and experimental autoimmune encephalomyelitis
    Nemanja U. Jovicic, Ilija D. Jeftic, Uglješa Jovičić · 2013 · PONS - medicinski casopis
  66. ATG in type 1 diabetes: an unanswered question
    Jay S. Skyler · 2013 · The Lancet Diabetes & Endocrinology
  67. MYELOID CELLS IN AUTOIMMUNE DISEASES
    Muhammad Sohel Mia · 2014 · Figshare
  68. OVERCOMING SELF-REACTIVITY THROUGH IMMUNOLOGICAL AND METABOLIC REDOX MODULATION
    Meghan M. Delmastro-Greenwood · 2012 · D-Scholarship@Pitt (University of Pittsburgh)
  69. Characteristics of GADA in Type 1 Diabetes following Immunomodulation with GAD65
    Mikael Chéramy · 2012 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  70. Autoantibodies related to type 1 diabetes in children
    Camilla Skoglund · 2011 · DiVA (Linkoping University)
  71. B cell deviations and type 1 diabetes in the NOD mouse
    Mia Sundström · 2012 · DiVA at Umeå University (Umeå University)
  72. Diabetes Pathogenesis - Role of Natural Killer Cells, T Cells and a Novel Neuropeptide
    Hanna Brauner · 2010 · Figshare
  73. Current Approaches and Future Prospects for the Prevention of β-Cell Destruction in Autoimmune Diabetes
    Carani B. Sanjeevi, Chengjun Sun · 2014 · Springer eBooks
  74. Nieuwe inzichten in therapeutische mogelijkheden bij diabetes mellitus type 1
    Jacqueline van Heiningen, Fleur M. Keij, Bart O. Roep · 2015 · Tijdschrift voor kindergeneeskunde
  75. Stress-inducible Mig6 promotes pancreatic beta cell destruction in the pathogenesis of diabetes
    Yi‐Chun Chen · 2014
  76. Vaccines for Type 1 Diabetes
    Sandeep Kumar Gupta · 2013 · Springer eBooks
  77. Étude de protection conférée par vaccination ADN dans un modèle murin d’hépatite auto-immune
    Catherine Habel · 2013
  78. Hétérogénéité du phénotype immunologique du diabète de type 1
    Danièle Dubois‐Laforgue · 2015 · Médecine des Maladies Métaboliques
  79. Addressing the Challenge of Autoimmunity in the Treatment of Diabetes with Stem Cells
    Karen English, Kathryn J. Wood · 2012 · Springer eBooks
  80. The Roles of Iddm30 and Iddm24 in the Immunopathogenesis of Type 1 Diabetes in BioBreeding Rats
    Ying-Chieh Gary Chao · 2015 · TSpace (University of Toronto)
  81. Mechanisms of transcriptional regulation in the maintenance of β cell function
    Aarthi V. Maganti · 2015 · IUScholarWorks (Indiana University)
  82. Expressão de fragmentos de anticorpos que reconhecem o antígeno CD20 humano
    Tarcila Zuleica Zaparolli Lopes · 2016
  83. Uloga B limfocita u razvoju multiple skleroze i eksperimentalnog autoimunskog encefalomijelitisa Role of B cells in the development of multiple sclerosis and experimental autoimmune encephalomyelitis
    Nemanja U. Jovicic, Ilija D. Jeftic, Uglješa Jovičić · 2013
  84. Intrathymic B cells as Mediators of Autoimmune Type 1 Diabetes
    Helen A. Davies · 2015 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  85. Les cellules stromales mésenchymateuses : Une thérapie cellulaire pour le diabète de type 1 ?
    Danièle Dubois‐Laforgue · 2016 · Médecine des Maladies Métaboliques
  86. Induction of Mixed Chimerism for Reversal of Autoimmunity in Type 1
    Defu Zeng · 2013
  87. I marker di efficacia nel disegno dei trial immunoterapici: le lezioni emergenti dal diabete di tipo 1
    Bart O. Roep, Mark Peakman, Marco Centanni · 2010 · L Endocrinologo
  88. Type 1 Diabetes: Past, Present, and Future Therapies
    Prachi Singh, Ganesh Rajendra Kokil, Karnaker R. Tupally, Kingshuk Poddar, Aaron Tan, Thirumalai Venkatesan, Harendra S. Parekh, Giorgia Pastorin · 2016 · SpringerBriefs in applied sciences and technology
  89. Evolution des auto-anticorps sous biothérapies
    Sophie Desplat‐Jégo · 2016 · Revue Francophone des Laboratoires
  90. Aspects of the Pre-Diabetic Period in Type 1 Diabetes
    Linda Åkerman · 2016 · Linköping University medical dissertations
  91. Insulin and Immunotherapy in Children and Adolescents with Type 1 Diabetes
    Johnny Ludvigsson · 2016 · Springer eBooks
  92. Srinath SandaShan WeiTessa Rue
    Heather ShillingCarla Greenbaum · 2013
  93. Metabolic outcomes of islet transplantation and correlation of graft function with hepatic imaging and immune response
    Augustin M. Brooks · 2015
  94. B cells in chronic antibody mediated rejection of renal transplants
    Laura McLaughlin · 2016 · Research Portal (King's College London)
  95. THE FIRST DIABETOGENIC MOVES
    Constantin Ionescu-Tirgoviste, Paul Aurelian Gagniuc, Roxana Adriana Stoica, Cristian Guja · 2015
  96. Therapeutic uses of stem cells in endocrinology.
    Ensieh Nasli‐Esfahani, Ardeshir Ghavamzadeh, Bagher A. Larijani · 2014 · Iranian Journal of Public Health
  97. Stem Cell Therapy for Type-1 Diabetes Mellitus
    Umang G. Thakkar, Aruna V. Vanikar, Hargovind L. Trivedi · 2017 · Stem cells in clinical applications
  98. Skeletal muscle fatigue: Investigating the role of cytokines, ROS and mitochondrial function.
    Kate E. Earl · 2016 · University of Liverpool
  99. Nanopartículas de insulina para administração oral
    Carolina Jacinto Correia · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  100. Transgenic expression of proinsulin to inactivate insulin-specific CD8+ T-cell responses in autoimmune diabetes
    Peta Reeves · 2016 · The University of Queensland